FF-10101 succinate is primarily utilized in medical research and pharmaceutical development to study its efficacy and safety in treating cancer, particularly leukemia and lymphoma. It is a compound designed to inhibit specific enzymes involved in cancer cell growth, making it a promising candidate for developing new anti-cancer drugs. Additionally, research explores its combination with other therapies to enhance treatment effectiveness and minimize potential side effects.